Page 11234..1020..»

Georgiamune Appoints Biopharma Veteran Mark Avagliano as Chief Business Officer to Drive Growth

Posted: November 20, 2024 at 2:48 am

GAITHERSBURG, Md., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage biotechnology company, announces the appointment of Mark Avagliano as Chief Business Officer. The news comes as Georgiamune closes out 2024 after having initiated three assets into clinical trials. With Phase 2 testing ambitions set for 2025 across the three clinical assets in both cancer and autoimmune diseases (GIM-122, GIM-531 and GIM-407), Avagliano’s combination of business acumen and sector expertise will further empower the company to meet these pivotal milestones while ensuring that its robust earlier stage pipeline progresses through development.

Here is the original post:
Georgiamune Appoints Biopharma Veteran Mark Avagliano as Chief Business Officer to Drive Growth

Posted in Global News Feed | Comments Off on Georgiamune Appoints Biopharma Veteran Mark Avagliano as Chief Business Officer to Drive Growth

Relmada Therapeutics to Present at Jefferies London Healthcare Conference

Posted: November 20, 2024 at 2:48 am

Conference being held November 19-21, 2024 Conference being held November 19-21, 2024

Read more here:
Relmada Therapeutics to Present at Jefferies London Healthcare Conference

Posted in Global News Feed | Comments Off on Relmada Therapeutics to Present at Jefferies London Healthcare Conference

MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders

Posted: November 20, 2024 at 2:48 am

NIH-funded Phase 2-3 ALS Expanded Access study expands reach of MediciNova’s ongoing COMBAT-ALS trial and provides illustration of Company’s development strategy NIH-funded Phase 2-3 ALS Expanded Access study expands reach of MediciNova’s ongoing COMBAT-ALS trial and provides illustration of Company’s development strategy

Go here to read the rest:
MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders

Posted in Global News Feed | Comments Off on MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders

Biopharma Leaders of Color (BLOC) Announces Board of Directors and Establishes Executive Council to Expand and Enhance Offerings

Posted: November 20, 2024 at 2:48 am

BLOC fosters and promotes the professional advancement of leaders of color in the life sciences space via curated networking, mentorship and education. BLOC fosters and promotes the professional advancement of leaders of color in the life sciences space via curated networking, mentorship and education.

See the rest here:
Biopharma Leaders of Color (BLOC) Announces Board of Directors and Establishes Executive Council to Expand and Enhance Offerings

Posted in Global News Feed | Comments Off on Biopharma Leaders of Color (BLOC) Announces Board of Directors and Establishes Executive Council to Expand and Enhance Offerings

Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities

Posted: November 20, 2024 at 2:48 am

Project is part of the U.S. Department of Defense’s BioMADE initiative to support U.S. bioindustrial manufacturing innovations and workforce development Project is part of the U.S. Department of Defense’s BioMADE initiative to support U.S. bioindustrial manufacturing innovations and workforce development

Go here to read the rest:
Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities

Posted in Global News Feed | Comments Off on Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities

Kaida BioPharma Announces Formation of Scientific Advisory Board to Support Development of KAD101 for Ovarian Cancer

Posted: November 20, 2024 at 2:48 am

Company appoints Anil K. Sood, MD, as inaugural member

Continue reading here:
Kaida BioPharma Announces Formation of Scientific Advisory Board to Support Development of KAD101 for Ovarian Cancer

Posted in Global News Feed | Comments Off on Kaida BioPharma Announces Formation of Scientific Advisory Board to Support Development of KAD101 for Ovarian Cancer

Synata Bio’s Sylonto Project Awarded $4.5 Million NDRC Grant

Posted: November 20, 2024 at 2:48 am

The waste carbon-to-ethanol facility will transform Henan Energy Group’s on-site waste gases into 50,000 tons of ethanol per year The waste carbon-to-ethanol facility will transform Henan Energy Group’s on-site waste gases into 50,000 tons of ethanol per year

Here is the original post:
Synata Bio’s Sylonto Project Awarded $4.5 Million NDRC Grant

Posted in Global News Feed | Comments Off on Synata Bio’s Sylonto Project Awarded $4.5 Million NDRC Grant

Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies

Posted: November 20, 2024 at 2:48 am

ORION CORPORATION INVESTOR NEWS 19 NOVEMBER 2024 at 18.30 EET

Here is the original post:
Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies

Posted in Global News Feed | Comments Off on Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies

Helio Genomics to Host Virtual KOL Event to Discuss Recent CLiMB Trial Data and Methylation Model Score in Patients with Hepatocellular Carcinoma…

Posted: November 20, 2024 at 2:48 am

IRVINE, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, today announced it will host a virtual KOL event on Monday, November 25, 2024 at 10:00 AM ET. To register, click here.

Follow this link:
Helio Genomics to Host Virtual KOL Event to Discuss Recent CLiMB Trial Data and Methylation Model Score in Patients with Hepatocellular Carcinoma...

Posted in Global News Feed | Comments Off on Helio Genomics to Host Virtual KOL Event to Discuss Recent CLiMB Trial Data and Methylation Model Score in Patients with Hepatocellular Carcinoma…

Conquer the New MJBizCon Expo Floor, One Pavilion at a Time

Posted: November 20, 2024 at 2:48 am

DENVER, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The 13th annual MJBizCon, the largest, most established cannabis business conference and expo in the world, opens with a more defined and inclusive expo show floor starting Wednesday, December 4, 2024 at the Las Vegas Convention Center.

Read more from the original source:
Conquer the New MJBizCon Expo Floor, One Pavilion at a Time

Posted in Global News Feed | Comments Off on Conquer the New MJBizCon Expo Floor, One Pavilion at a Time

Page 11234..1020..»